LICENSE, SUPPLY AND CONTRACT MANUFACTURING AGREEMENT by and among SYNERX PHARMA, LLC and BIONICHE TEORANTA and DELCATH SYSTEMS, INC. 50MG MELPHALAN HYDROCHLORIDE FOR INJECTION VIALS FOR INTRA-ARTERIAL USE OCTOBER 13, 2010License, Supply and Contract Manufacturing Agreement • March 8th, 2011 • Delcath Systems Inc • Surgical & medical instruments & apparatus • New York
LICENSE, SUPPLY AND CONTRACT MANUFACTURING AGREEMENTLicense, Supply and Contract Manufacturing Agreement • August 5th, 2024 • Delcath Systems, Inc. • Surgical & medical instruments & apparatus
This Fifth Amendment to the License, Supply, and Contract Manufacturing Agreement ("Fifth Amendment") is made and entered into as of May 1, 2024 ("Fifth Amendment Effective Date") between Synerx Pharma, LLC, a Pennsylvania limited liability company (“Synerx”) and Mylan Teoranta, a limited company formed under the laws of the Republic of Ireland (“Mylan Teoranta”) (Synerx and Mylan Teoranta are sometimes referred to collectively as “Mylan”); and Delcath Systems, Inc. (“Delcath”). Synerx, Mylan Teoranta and Delcath may be referred to herein individually as a "Party" and together as the "Parties".
